ProShare Advisors Portfolio holdings
AUM
$50.1B
This Quarter Return
+3.29%
1 Year Return
+23.39%
3 Year Return
+95.6%
5 Year Return
+167.57%
10 Year Return
+417.51%
AUM
$43.8B
AUM Growth
+$43.8B
(+7.2%)
Cap. Flow
+$3.15B
Cap. Flow
% of AUM
7.2%
Top 10 Holdings %
Top 10 Hldgs %
29.71%
Holding
2,321
New
256
Increased
1,693
Reduced
321
Closed
50
Top Buys
| 1 |
Apple
AAPL
|
$433M |
| 2 |
NVIDIA
NVDA
|
$385M |
| 3 |
Microsoft
MSFT
|
$378M |
| 4 |
Amazon
AMZN
|
$271M |
| 5 |
Palantir
PLTR
|
$192M |
Top Sells
| 1 |
Walmart
WMT
|
$297M |
| 2 |
NextEra Energy, Inc.
NEE
|
$191M |
| 3 |
West Pharmaceutical
WST
|
$175M |
| 4 |
Broadcom
AVGO
|
$166M |
| 5 |
Meta Platforms (Facebook)
META
|
$128M |
Sector Composition
| 1 | Technology | 32.43% |
| 2 | Consumer Discretionary | 10.78% |
| 3 | Consumer Staples | 10.15% |
| 4 | Industrials | 10.05% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KG
2201
Kestrel Group, Ltd.
KG
$200M
| $41.9K | ﹤0.01% |
24,790
+8,158
| +49% | +$13.8K |
|
2202
Wheels Up
UP
$1.66B
| $41.7K | ﹤0.01% |
25,258
-8,636
| -25% | -$14.3K |
|
2203
Compass Therapeutics
CMPX
$470M
| $41.6K | ﹤0.01% |
28,722
+9,451
| +49% | +$13.7K |
|
2204
AbCellera Biologics
ABCL
$1.22B
| $41K | ﹤0.01% |
13,990
-3,422
| -20% | -$10K |
|
2205
Entravision Communication
EVC
$224M
| $40.7K | ﹤0.01% |
17,318
+5,699
| +49% | +$13.4K |
|
2206
Destination XL Group
DXLG
$70M
| $40.6K | ﹤0.01% |
15,091
+4,967
| +49% | +$13.4K |
|
2207
TScan Therapeutics
TCRX
$100M
| $39.9K | ﹤0.01% |
+13,140
| New | +$39.9K |
|
2208
Rimini Street
RMNI
$392M
| $39.9K | ﹤0.01% |
14,942
+4,918
| +49% | +$13.1K |
|
2209
Holley
HLLY
$457M
| $39.6K | ﹤0.01% |
+13,112
| New | +$39.6K |
|
|
GPMT
2210
Granite Point Mortgage Trust
GPMT
$137M
| $39.6K | ﹤0.01% |
+14,179
| New | +$39.6K |
|
|
NVRO
2211
DELISTED
NEVRO CORP.
NVRO
| $38.5K | ﹤0.01% |
10,351
-3,313
| -24% | -$12.3K |
|
2212
GoPro
GPRO
$240M
| $38.4K | ﹤0.01% |
35,247
+11,598
| +49% | +$12.6K |
|
2213
E.W. Scripps
SSP
$261M
| $38.2K | ﹤0.01% |
17,268
+5,819
| +51% | +$12.9K |
|
2214
Blink Charging
BLNK
$129M
| $37.7K | ﹤0.01% |
27,095
+8,916
| +49% | +$12.4K |
|
2215
Ventyx Biosciences
VTYX
$180M
| $37.5K | ﹤0.01% |
17,116
+1,457
| +9% | +$3.19K |
|
2216
Lyell Immunopharma
LYEL
$220M
| $37.4K | ﹤0.01% |
58,482
+12,988
| +29% | +$8.31K |
|
2217
Caribou Biosciences
CRBU
$174M
| $36.8K | ﹤0.01% |
23,170
+2,284
| +11% | +$3.63K |
|
2218
Lexicon Pharmaceuticals
LXRX
$403M
| $36.5K | ﹤0.01% |
49,460
+6,404
| +15% | +$4.73K |
|
2219
Sight Sciences
SGHT
$194M
| $36.4K | ﹤0.01% |
+10,004
| New | +$36.4K |
|
2220
HF Foods Group
HFFG
$173M
| $36.4K | ﹤0.01% |
+11,339
| New | +$36.4K |
|
2221
Stereotaxis
STXS
$246M
| $36.3K | ﹤0.01% |
15,913
+5,556
| +54% | +$12.7K |
|
2222
CureVac
CVAC
$1.21B
| $36.2K | ﹤0.01% |
10,627
-2,629
| -20% | -$8.97K |
|
2223
Puma Biotechnology
PBYI
$262M
| $36.2K | ﹤0.01% |
+11,853
| New | +$36.2K |
|
|
QIPT
2224
Quipt Home Medical
QIPT
$114M
| $35.5K | ﹤0.01% |
+11,650
| New | +$35.5K |
|
2225
Zura Bio
ZURA
$130M
| $34.7K | ﹤0.01% |
+13,894
| New | +$34.7K |
|